Performance of 18F-FDG PET/CT in Selecting Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology for Surgery. A Systematic Review and a Meta-Analysis

Thyroid nodules with indeterminate fine-needle aspiration cytology (FNA) represent a major challenge in clinical practice. We conducted a systematic review and meta-analysis evaluating the ability of hybrid imaging using fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to appropriately select these nodules for surgery. PubMed, CENTRAL, Scopus, and Web of Science were searched until July 2019. Original articles reporting data on the performance of 18F-FDG PET/CT in thyroid nodules with indeterminate FNA were included. Summary operating points including 95% confidence interval values (95% CI) were estimated using a random-effects model. Out of 786 retrieved papers, eight studies evaluating 104 malignant and 327 benign thyroid nodules were included. The pooled positive and negative likelihood ratios (LR+ and LR-) and diagnostic odds ratio (DOR) of 18F-FDG PET/CT were 1.7 (95% CI: 1.4–2.0), 0.4 (95% CI: 0.2–0.7), and 3.5 (95% CI: 1.7–7.1), respectively. No heterogeneity was found for LR+ and DOR. In patients with thyroid nodules with indeterminate FNA, 18F-FDG PET/CT has a moderate ability to correctly discriminate malignant from benign lesions and could represent a reliable option to reduce unnecessary diagnostic surgeries. However, further studies using standardized criteria for interpretation are needed to confirm the reproducibility of these findings.

[1]  M. Walter,et al.  Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules. , 2019, Gland surgery.

[2]  P. Trimboli,et al.  PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art , 2019, Reviews in Endocrine and Metabolic Disorders.

[3]  P. Trimboli,et al.  Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis , 2018, Endocrine.

[4]  A. Piccardo,et al.  Role of positron emission tomography in thyroid and neuroendocrine tumors. , 2018, Minerva endocrinologica.

[5]  C. Godballe,et al.  PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia , 2018, European Archives of Oto-Rhino-Laryngology.

[6]  J. Hamming,et al.  Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules , 2018, Endocrine reviews.

[7]  David Moher,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement , 2018, JAMA.

[8]  E. Cibas,et al.  The 2017 Bethesda System for Reporting Thyroid Cytopathology. , 2017, Journal of the American Society of Cytopathology.

[9]  L. Lavra,et al.  Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology , 2017, Oncotarget.

[10]  G. Treglia,et al.  Systematic reviews and meta-analyses of diagnostic studies: a practical guideline , 2017, Clinical and Translational Imaging.

[11]  W. Leslie,et al.  A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms , 2016, Annals of medicine and surgery.

[12]  Paolo Vitti,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  F. Paparo,et al.  Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. , 2016, European journal of endocrinology.

[14]  B. Corvilain,et al.  Is there still a role for thyroid scintigraphy in the workup of a thyroid nodule in the era of fine needle aspiration cytology and molecular testing? , 2016, F1000Research.

[15]  P. Trimboli,et al.  BRAF‐mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta‐analysis , 2016, Clinical endocrinology.

[16]  P. Trimboli,et al.  Molecular imaging with 99mTc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  E. Rossi,et al.  A meta‐analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated? , 2015, Cancer cytopathology.

[18]  P. Trimboli,et al.  DIAGNOSIS OF ENDOCRINE DISEASE: High-yield thyroid fine-needle aspiration cytology: an update focused on ancillary techniques improving its accuracy. , 2015, European journal of endocrinology.

[19]  M. Luster,et al.  Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule , 2015, European journal of clinical investigation.

[20]  Sarah J. Johnson,et al.  Guidelines for the management of thyroid cancer , 2014, Clinical endocrinology.

[21]  D. Vriens,et al.  Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. , 2014, The Journal of clinical endocrinology and metabolism.

[22]  E. Papini,et al.  Italian consensus for the classification and reporting of thyroid cytology , 2014, Journal of Endocrinological Investigation.

[23]  P. Trimboli,et al.  Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis , 2014, Endocrine.

[24]  Paolo Eusebi,et al.  Diagnostic Accuracy Measures , 2013, Cerebrovascular Diseases.

[25]  Yingli Lu,et al.  Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? a meta-analysis of the literature , 2013, Journal of Otolaryngology - Head & Neck Surgery.

[26]  L. Giovanella,et al.  PET and PET/CT imaging in thyroid and adrenal diseases: an update , 2013, Hormones.

[27]  M. Salvatori,et al.  The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview , 2013, European Archives of Oto-Rhino-Laryngology.

[28]  M. Torre,et al.  Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm? , 2013, Langenbeck's Archives of Surgery.

[29]  L. Ceriani,et al.  Diagnostic performance of 99mTc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis , 2013, Endocrine.

[30]  G. Treglia,et al.  Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art , 2013, Clinical and Translational Imaging.

[31]  E. Baudin,et al.  Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? , 2012, Thyroid : official journal of the American Thyroid Association.

[32]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[33]  D. Vriens,et al.  The role of [(18)F]-2-fluoro-2deoxy-d-dglucose-positron emission tomography in thyroid nodules iwht indeterminate fine-needle aspiration biopsy: sysematic review and meta-analysis of the literature , 2011 .

[34]  A. Bondi,et al.  Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. , 2010, Pathologica.

[35]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[36]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[37]  P. Trimboli,et al.  Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm , 2009, Diagnostic cytopathology.

[38]  J. Aberle,et al.  Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination , 2009, European journal of clinical investigation.

[39]  H. Mårtensson,et al.  Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients , 2008, Langenbeck's Archives of Surgery.

[40]  J. Medina,et al.  Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? , 2008, American journal of otolaryngology.

[41]  A. Gawande,et al.  Long‐term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation , 2007, Cancer.

[42]  P. Hasselgren,et al.  Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. , 2005, Surgery.

[43]  P. Bossuyt,et al.  The diagnostic odds ratio: a single indicator of test performance. , 2003, Journal of clinical epidemiology.

[44]  L. Hegedüs,et al.  Management of simple nodular goiter: current status and future perspectives. , 2003, Endocrine reviews.

[45]  Z. Baloch,et al.  Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology , 2002, Diagnostic cytopathology.

[46]  M. Castro,et al.  Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules. , 2017, Thyroid : official journal of the American Thyroid Association.

[47]  D. Vriens,et al.  The role of [18F]‐2‐fluoro‐2‐deoxy‐d‐glucose–positron emission tomography in thyroid nodules with indeterminate fine‐needle aspiration biopsy , 2011, Cancer.